NCT02135042 2026-03-18
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
Phase 2/3 Active not recruiting
NRG Oncology
Affiliated Hospital of Guangdong Medical University
Fujian Cancer Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School